Sumatriptan, a selective serotonin receptor agonist (5-HT1B/1D), is typically administered via subcutaneous injection or nasal spray at the onset of a cluster headache to rapidly constrict cerebral blood vessels and inhibit neurogenic inflammation. Its quick absorption and targeted mechanism allow for rapid symptomatic relief by reducing pain signal transmission and alleviating vascular changes associated with cluster headache pathophysiology.